Literature DB >> 18024908

Rescue of Akabane virus (family Bunyaviridae) entirely from cloned cDNAs by using RNA polymerase I.

Yohsuke Ogawa1, Keita Sugiura, Kentaro Kato, Yukinobu Tohya, Hiroomi Akashi.   

Abstract

Reverse-genetic systems are often used to study different aspects of the viral life cycle. To date, three rescue systems have been developed for the family Bunyaviridae. These systems use T7 RNA polymerase, which is generally used in rescue systems for Mononegavirales. In the present study, we describe a rescue system for Akabane virus (family Bunyaviridae) that uses cDNAs and RNA polymerase I instead of T7 RNA polymerase. The utility of this system was demonstrated by the generation of a mutant with a deletion of the non-structural protein (NSs) on the S RNA segment. These results offer a new option for bunyavirus rescue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18024908     DOI: 10.1099/vir.0.83173-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function.

Authors:  Eric Bergeron; César G Albariño; Marina L Khristova; Stuart T Nichol
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

2.  Characterization of a recombinant Akabane mutant virus with knockout of a nonstructural protein NSs in a pregnant goat model.

Authors:  Akiko Takenaka-Uema; Norasuthi Bangphoomi; Chieko Shioda; Kazuyuki Uchida; Fumihiro Gen; Kentaro Kato; Takeshi Haga; Shin Murakami; Hiroomi Akashi; Taisuke Hoimoto
Journal:  Virol Sin       Date:  2016-06       Impact factor: 4.327

3.  Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.

Authors:  Takahiro Masaki; Ryosuke Suzuki; Mohsan Saeed; Ken-ichi Mori; Mami Matsuda; Hideki Aizaki; Koji Ishii; Noboru Maki; Tatsuo Miyamura; Yoshiharu Matsuura; Takaji Wakita; Tetsuro Suzuki
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

Review 4.  Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses.

Authors:  Thomas Hoenen; Allison Groseth; Fabian de Kok-Mercado; Jens H Kuhn; Victoria Wahl-Jensen
Journal:  Antiviral Res       Date:  2011-06-14       Impact factor: 5.970

5.  Deletion mutants of Schmallenberg virus are avirulent and protect from virus challenge.

Authors:  Franziska Kraatz; Kerstin Wernike; Silke Hechinger; Patricia König; Harald Granzow; Ilona Reimann; Martin Beer
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

6.  Oropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and type I interferon signaling pathways in nonmyeloid cells.

Authors:  Jose Luiz Proenca-Modena; Renata Sesti-Costa; Amelia K Pinto; Justin M Richner; Helen M Lazear; Tiffany Lucas; Jennifer L Hyde; Michael S Diamond
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

7.  Generation of a Recombinant Akabane Virus Expressing Enhanced Green Fluorescent Protein.

Authors:  Akiko Takenaka-Uema; Yousuke Murata; Fumihiro Gen; Yukari Ishihara-Saeki; Ken-Ichi Watanabe; Kazuyuki Uchida; Kentaro Kato; Shin Murakami; Takeshi Haga; Hiroomi Akashi; Taisuke Horimoto
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

8.  RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses.

Authors:  Agnès Billecocq; Nicolas Gauliard; Nicolas Le May; Richard M Elliott; Ramon Flick; Michèle Bouloy
Journal:  Virology       Date:  2008-07-09       Impact factor: 3.616

Review 9.  Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

Authors:  Michele Bouloy; Ramon Flick
Journal:  Antiviral Res       Date:  2009-08-12       Impact factor: 5.970

Review 10.  Orthobunyaviruses: recent genetic and structural insights.

Authors:  Richard M Elliott
Journal:  Nat Rev Microbiol       Date:  2014-09-08       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.